The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...
A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...
Zealand Pharma reports 2024 results but no partnering deal for petrelintide. CEO Adam Steensberg remains confident despite ...
An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...
However, positive early-stage results for its once weekly Amycretin obesity drug, which similarly employs the amylin pancreas hormone, led the stock higher last month. Novo Nordisk said Wednesday ...
However, positive early-stage results for its once weekly Amycretin obesity drug, which similarly employs the amylin pancreas hormone, led the stock higher last month. Novo Nordisk said Wednesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback